Clark Nisse V, Einarsson Jon I
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
JSLS. 2019 Jan-Mar;23(1). doi: 10.4293/JSLS.2018.00098.
An increasing number of women are seeking removal of the Essure sterilization device due to symptoms including pelvic pain, abnormal bleeding, and allergic reaction. A fraction of these women also desire a future pregnancy and request sterilization reversal at the time of device removal. We present a novel technique for Essure reversal in addition to our experience with three cases.
Simultaneous laparoscopy and hysteroscopy is used to remove the device followed by laparoscopic reimplantation of the distal fallopian tube to the uterine fundus. A video of our method is included and the outcomes of three patients reported.
Three women underwent laparoscopic Essure reversal for device-attributed symptoms and desire to restore fertility between 2017 and 2018. All procedures were uncomplicated with restoration of tubal patency in one or both fallopian tubes on follow-up hysterosalpingogram. Over a period of 4 to 10 months of followup, no pregnancies have been reported.
Essure reversal is a feasible technique for removing the device and restoring tubal patency; however, more data are needed on pregnancy outcomes following this novel procedure.
越来越多的女性因盆腔疼痛、异常出血和过敏反应等症状寻求取出Essure绝育装置。这些女性中的一部分人还希望未来怀孕,并在取出装置时要求进行绝育逆转。除了我们对三例病例的经验外,我们还介绍了一种新型的Essure逆转技术。
同时使用腹腔镜和宫腔镜取出装置,然后通过腹腔镜将远端输卵管重新植入子宫底部。文中包含了我们方法的视频,并报告了三名患者的结果。
2017年至2018年期间,三名女性因装置相关症状并希望恢复生育能力而接受了腹腔镜Essure逆转手术。所有手术均无并发症,随访子宫输卵管造影显示一侧或双侧输卵管恢复通畅。在4至10个月的随访期内,未报告有怀孕情况。
Essure逆转是一种可行的取出装置并恢复输卵管通畅的技术;然而,关于这一新型手术的妊娠结局还需要更多数据。